102
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective

, , &
Pages 2753-2761 | Published online: 18 Sep 2017

References

  • World Health Organization [webpage on the Internet]Burden of COPDGenevaWorld Health Organization2017 Available from: http://www.who.int/respiratory/copd/burden/en/Accessed January 23, 2017
  • LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
  • Australian Institute of Health and Welfare [webpage on the Internet]Australia’s Health 20162016 Available from: http://www.aihw.gov.au/copd/Accessed February 23, 2017
  • HillKGoldsteinRSGuyattGHPrevalence and under-diagnosis of chronic obstructive pulmonary disease among patients at risk in primary careCMAJ2010182767367820371646
  • BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and under-diagnosis of COPD in the primary care settingThorax200863540240718234906
  • VandevoordeJVerbanckSGijsselsLEarly detection of COPD: a case finding study in general practiceRespir Med2007101352553016908127
  • JordanRELamKBChengKKCase finding for chronic obstructive pulmonary disease: a model for optimising a targeted approachThorax201065649249820522845
  • XuanWToelleBGBirdTPrevalence of respiratory symptoms, illnesses and spirometric diagnoses by age group and sex: the burden of lung disease (BOLD) studyA50. COPD EpidemiologyAmerican Thoracic Society2011183A1734Denver, Colorado
  • LindbergABjerg-BacklundARonmarkELarssonLGLundbackBPrevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking report from the obstructive lung disease in Northern Sweden StudiesRespir Med2006100226427215975774
  • Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: www.goldcopd.orgAccessed March 30, 2017
  • AkazawaMHalpernRRiedelAAStanfordRHDalalABlanchetteCMEconomic burden prior to COPD diagnosis: a matched case-control study in the United StatesRespir Med2008102121744175218760581
  • VermeirePThe burden of chronic obstructive pulmonary diseaseRespir Med200296suppl CS3S10
  • LevyMLQuanjerPHBookerRCooperBGHolmesSSmallIDiagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendationsPrim Care Respir J200918313014719684995
  • FabbriLMBoschettoPMappCECOPD guidelines: the important thing is not to stop questioningAm J Respir Crit Care Med2007176652752817823358
  • SorianoJBZielinskiJPriceDScreening for and early detection of chronic obstructive pulmonary diseaseLancet2009374969172173219716965
  • HanMKKimMGMardonRSpirometry utilization for COPD: how do we measure up?Chest2007132240340917550936
  • JooMJLeeTAWeissKBGeographic variation of spirometry use in newly diagnosed COPDChest20081341384518347201
  • WiltTJNiewoehnerDKimCUse of Spirometry for Case Finding, Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD). Summary, Evidence Report/Technology Assessment No. 12Rockville, MDAgency for Healthcare Research and Quality Prepared by the Minnesota Evidence-Based Practice Center2005AHRQ Publication No: 05-E017-1 Contract No: 290-02-0009
  • FrithPCrockettABeilbyJSimplified COPD screening: validation of the PiKo-6® in primary carePrim Care Respir J201120219019821597667
  • Van den BemtLWoutersBCGrootensJDenisJPoelsPJSchermerTRDiagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional studyNPJ Prim Care Respir Med2014241403325119686
  • JingJYHuangTCCuiWXuFShenHHShould FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A meta-analysisChest2009135499199819349398
  • The Pharmacy Guild of AustraliaServing Australians: A system of community pharmacy2016 Available from: https://www.guild.org.au/__data/assets/pdf_file/0020/5942/serving-australians-a-system-of-community-pharmacy.pdfAccessed August 30, 2017
  • YangIADabscheckEGeorgeJThe COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2017 Version 2.50, June 2017. Available from: http://copdx.org.au/copd-x-plan/Accessed August 30, 2017
  • SichletidisLSpyratosDPapaioannouMA combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care settingPrim Care Respir J201120218418921597666
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
  • AllanHDiamandisSSainiBMarshallDGavagnaGPeterson-ClarkGA Collaborative Screening, Referral and Management Process to Improve Health Outcomes in Chronic Obstructive Pulmonary Disease (COPD)2017 Available from: http://6cpa.com.au/wp-content/uploads/A-Collaborative-Screening-Referral-and-Management-Process-to-Improve-Health-Outcomes-in-Chronic-Obstructive-Pulmonary-Disease-COPD-Final-Report-Appendices-Part-Final-Report.pdfAccessed August 4, 2017
  • Lung FoundationThe Results Record Form for COPD Case Finding – Pharmacy2017 Available from: http://lungfoundation.com.au/wp-content/uploads/2014/02/Results-Form-Pharmacy-20170314.pdfAccessed August 8, 2017
  • ToelleBGXuanWBirdTERespiratory symptoms and illness in older Australians: the burden of obstructive lung disease (BOLD) studyMed J Aust2013198314414823418694
  • US Preventive Services Task Force (USPSTF)SiuALBibbins-DomingoKScreening for chronic obstructive pulmonary disease US preventive services task force recommendation statementJAMA2016315131372137727046365
  • CastilloDBurgosFGuaytaRFARMAEPOC groupAirflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosisRespir Med2015109447548225754101
  • AIHW [webpage on the Internet]Australia’s Health 2016. Australia’s Health No. 15. Cat. No. AUS 199CanberraAIHW2016 Available from: http://www.aihw.gov.au/rural-health/access-to-health-services/Accessed May 14, 2017
  • ZwarNBunkerJMReddelHKEarly intervention for chronic obstructive pulmonary disease by practice nurse and GP teams: a cluster randomized trialFam Pract201633666367027535327
  • BereznickiBWaltersHWaltersJPetersonGBereznickiLInitial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal faceIntern Med J201747780781310.1111/imj.1341828276136
  • QuanjerPHStanojevicSColeTJBaurXHallGLCulverBMulti-ethnic reference values for spirometry for the 3–95 year age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
  • WrightDTwiggMThornleyTChronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health interventionInt J Pharm Pract2015231838525371146
  • CastilloDGuaytaRGinerJFARMAEPOC groupCOPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot studyRespir Med2009103683984519200706
  • FullerLConradWFHeatonPCPanosREschenbacherWFredeSMPharmacist-managed chronic obstructive pulmonary disease screening in a community settingJ Am Pharm Assoc2012525e59e66